We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$2.04B
AUM Growth
+$230M
Cap. Flow
+$71.7M
Cap. Flow %
3.52%
Top 10 Hldgs %
50.3%
Holding
303
New
23
Increased
82
Reduced
59
Closed
14

Top Buys

Rank Stock Value
1
VOO icon
Vanguard S&P 500 ETF
VOO
+$33M
2
BXSL icon
Blackstone Secured Lending
BXSL
+$17.3M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$14.2M
4
VUG icon
Vanguard Morningstar Growth ETF
VUG
+$12.2M
5
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$8.61M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$39.2M
2
AAPL icon
Apple
AAPL
+$7.17M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$4.21M
4
VTV icon
Vanguard Morningstar Value ETF
VTV
+$3.07M
5
IHI icon
iShares US Medical Devices ETF
IHI
+$2.8M

Sector Composition

Rank Sector Weight
1 Financials 10.42%
2 Technology 8.49%
3 Healthcare 4.75%
4 Communication Services 3.92%
5 Consumer Discretionary 3.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PMN icon
276
ProMIS Neurosciences
PMN
$130M
$191K 0.01%
4,000
– –
LBTYK icon
277
Liberty Global Class C
LBTYK
$3.46B
$183K 0.01%
10,386
– –
ETWO
278
DELISTED
E2open Parent Holdings
ETWO
$167K 0.01%
37,615
+1,000
+3% +$4.04K
MGNX icon
279
MacroGenics
MGNX
$256M
$147K 0.01%
10,000
– –
PNBK icon
280
Patriot National Bancorp
PNBK
$139M
$147K 0.01%
39,123
– –
CLSD
281
DELISTED
Clearside Biomedical
CLSD
$142K 0.01%
6,200
– –
MYN icon
282
BlackRock MuniYield New York Quality Fund
MYN
$376M
$105K 0.01%
10,000
– –
AWH
283
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$72.7K ﹤0.01%
23,436
– –
HTZWW
284
Hertz Global Holdings Warrants
HTZWW
$112M
$71.3K ﹤0.01%
16,050
+500
+3% +$2.35K
ALTM
285
DELISTED
Arcadium Lithium plc
ALTM
$67.9K ﹤0.01%
+15,752
New +$79K
CGTX icon
286
Cognition Therapeutics
CGTX
$98.9M
$44.6K ﹤0.01%
24,500
– –
RLYB icon
287
Rallybio
RLYB
$88.1M
$40.9K ﹤0.01%
+2,761
New +$38.5K
AKLI
288
DELISTED
Akili Inc
AKLI
$16.4K ﹤0.01%
56,554
– –
VERU icon
289
Veru
VERU
$46.7M
$11.4K ﹤0.01%
1,630
– –
ACWI icon
290
iShares MSCI ACWI ETF
ACWI
$33.4B
– –
-2,421
Closed -$246K
APA icon
291
APA Corp
APA
$14B
– –
-5,783
Closed -$207K
ATI icon
292
ATI
ATI
$31.4B
– –
-8,180
Closed -$372K
BAC.PRL icon
293
Bank of America Series L
BAC.PRL
$4.02B
– –
-184
Closed -$222K
BDX icon
294
Becton Dickinson
BDX
$50B
– –
-848
Closed -$207K
CAT icon
295
Caterpillar
CAT
$393B
– –
-692
Closed -$205K
DOW icon
296
Dow Inc
DOW
$22.1B
– –
-3,831
Closed -$210K
KDP icon
297
Keurig Dr Pepper
KDP
$40.2B
– –
-11,475
Closed -$382K
KLAC icon
298
KLA
KLAC
$272B
– –
-6,850
Closed -$398K
MFIC icon
299
MidCap Financial Investment
MFIC
$795M
– –
-43,733
Closed -$598K
SCHW
300
Charles Schwab
SCHW
$189B
– –
-35,319
Closed -$2.43M
9 10 11
12
13

Similar funds

MC
Martin Currie Edinburgh, United Kingdom $2.61B AUM 29.41% 1-Year Est. Return
WBA
Walgreens Boots Alliance Deerfield, Illinois $2.24B AUM 36.34% 1-Year Est. Return
MD
Money Design Tokyo, Japan $2.14B AUM 10.33% 1-Year Est. Return
GL
Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return
SVCF
Silicon Valley Community Foundation Mountain View, California $1.77B AUM 13% 1-Year Est. Return
GLA
Good Life Advisors Reading, Pennsylvania $1.6B AUM 15.83% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
MME
Meag Munich Ergo Munich, Germany $3.54B AUM 20% 1-Year Est. Return

Northeast Financial Consultants's Q1 2024 Portfolio in Review

As of Q1 2024, Northeast Financial Consultants held 303 positions worth $2.04B, up 13% from $1.81B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Northeast Financial Consultants deployed $71.7M of net new capital in Q1 2024, opening 23 new positions and adding to 82 existing holdings. Its largest new stake was iShares Expanded Tech Sector ETF: 77,994 shares worth $6.72M.

By sector, the portfolio is most concentrated in Financials at 10% of assets, up from 9.4% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Pfizer, an estimated $39.2M trimmed.

  • Northeast Financial Consultants's largest Q1 2024 buy was iShares Expanded Tech Sector ETF: 77,994 shares worth $6.72M.
  • Northeast Financial Consultants added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $33M increase.
  • Northeast Financial Consultants's biggest Q1 2024 reduction was Pfizer, cutting an estimated $39.2M.
  • Northeast Financial Consultants fully exited Charles Schwab in Q1 2024, selling an estimated $2.43M.
  • Northeast Financial Consultants's ten largest holdings make up 50% of its $2.04B portfolio in Q1 2024.
  • Northeast Financial Consultants opened 23 new positions and closed 14 in Q1 2024.
  • Northeast Financial Consultants's portfolio value rose 13% quarter-over-quarter to $2.04B.

Based on Northeast Financial Consultants's 13F filing for Q1 2024, filed 15 May 2024.